首页> 外文期刊>Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases >Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua
【24h】

Large increase of rotavirus diarrhoea in the hospital setting associated with emergence of G12 genotype in a highly vaccinated population in Nicaragua

机译:在尼加拉瓜高疫苗的群体中,在尼加拉瓜高疫苗的群体出现的医院环境中大幅增加

获取原文
获取原文并翻译 | 示例
           

摘要

Rotaviruses (RVs) are a major cause of severe diarrhoea in young children. Nicaragua introduced routine immunization with the pentavalent RV vaccine (RV5) in 2006, which greatly reduced the incidence of diarrhoea. A remaining concern has been the possible emergence of new RV strains to which the vaccination has less effect. In this study, 837 children with diarrhoea in hospital settings were investigated for RV between May 2011 and July 2013. RVs were subsequently typed by multiplex PCR and/or sequencing. Fecal anti-RV IgA titres for a subset of RV-infected (n = 137) and noninfected children (n = 52) were determined with an in-house enzyme-linked immunosorbent assay. The RV detection rate was 8% in 2011, followed by a sharp increase to 29% in 2012 and 19% in 2013. This was associated with emergence and predominance of genotype G12 RV, from 0% in 2011 to 66% in 2012 and 82% in 2013, infecting children from 1 month to 10 years of age. Two sequenced G12 strains showed a Wa-like genome with genotype G12-P[ 8]-I1-R1-C1-M1-A1-N1-T1-E1-H1, similar to the globally emerging G12 strains. Fecal anti-RV IgA analysis showed that most G12-infected and noninfected children had been in contact with either vaccine or wild RV strains, but such antibodies did not prevent symptomatic G12 infection. A marked increase of RV was evident in the hospital setting associated with a nationwide emergence and predominance of RV G12 genotype in a population with high RV5 vaccine coverage.
机译:轮状病毒(RVS)是幼儿严重腹泻的主要原因。尼加拉瓜于2006年与五价RV疫苗(RV5)引入了常规免疫,这大大降低了腹泻的发生率。其余的担忧是疫苗接种效果较小的新RV菌株的可能出现。在本研究中,在2011年5月和2013年7月期间,研究了837名患有医院环境中的腹泻儿童。随后通过多重PCR和/或测序来键入RV。用内部酶联免疫吸附测定测定RV感染(n = 137)和无感染儿童(n = 52)的粪便抗RV IgA滴度。 2011年,RV检测率为8%,随后2012年的急剧增长至29%,2013年为19%。这与基因型G12 RV的出现和优势有关,2012年的0%至2012年和82%至66%。 %在2013年,感染1个月至10岁儿童。两个测序的G12菌株显示出具有基因型G12-P [8] -I1-R1-C1-M1-A1-N1-T1-E1-H1的WA样基因组,类似于全球出现的G12菌株。粪便抗RV IgA分析表明,大多数G12感染和无感染的儿童都与疫苗或野生RV菌株接触,但这种抗体没有防止症状G12感染。在与高RV5疫苗覆盖率的群体中,在与全国性的出现和职称相关的群体的出现和优势相关的医院环境中,RV的显着增加是显而易见的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号